Aegon Ltd. Financial Ratings Affirmed
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 13 2026
0mins
Source: Newsfilter
- Financial Strength Rating: AM Best has affirmed the Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of 'a+' (Excellent) for Aegon Ltd.'s U.S. life/health subsidiaries, indicating strong balance sheet strength and stable outlook.
- Capital Adequacy: Aegon USA's risk-adjusted capitalization is assessed as strong to very strong, with AM Best expecting this robust capital adequacy to be maintained in the near term, ensuring substantial financial flexibility and borrowing capacity.
- Diversified Business: Aegon USA's overall premiums increased in 2024 and remained stable through the first three quarters of 2025, with its diversified product lines contributing positively to operating earnings, reflecting a favorable business profile.
- Strategic Relocation: Aegon Ltd. plans to relocate its headquarters to the U.S. by 2028 and will be renamed Transamerica Inc., aiming to prioritize resources towards building a leading U.S. life insurance and retirement company, thereby enhancing its competitive position in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AEG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AEG
About AEG
Aegon Ltd. (Aegon) is an international financial service holding company. The Company offers products and services across insurance, long-term savings, banking and asset management. In the United States, the Company operates under two brands: Transamerica and World Financial Group Insurance Agency, which offers life insurance, investments and retirement solutions. In the Netherlands, Aegon focuses on life insurance, long-term savings, pension and annuity solutions, and mortgages. In the United Kingdom, Aegon is the investment platform, providing a range of investment, retirement solutions, and protection products to individuals, advisers, and employers. In China, the Company owns a stake in Aegon THTF Life Insurance Company, which offers life insurance solutions through a network of branches, primarily in eastern China. It also has a partnership with Banco Santander to distribute life, health, and non-life insurance products through the bank’s branches in Spain and Portugal.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aegon Restructures Leadership to Accelerate Strategic Execution
- Leadership Restructuring: Aegon has announced a leadership restructuring effective January 1, 2027, with Will Fuller assuming the role of President and COO, aimed at accelerating strategic execution and supporting the planned relocation of its global headquarters to the U.S.
- Headquarters Relocation: Aegon has officially selected New York City as the location for its future global headquarters, with a new office set to open in mid-2027, which will consolidate core corporate functions and enhance collaboration among the executive leadership team.
- Executive Experience: Will Fuller, who has served as President and CEO of Transamerica since March 2021, brings extensive industry experience from senior roles at Lincoln Financial Group and Merrill Lynch, and will oversee the day-to-day management of Transamerica and Aegon’s international businesses.
- Governance Reform Partnership: Aegon is partnering with major shareholders to overhaul its governance structure to support its relocation plans in the U.S., further simplifying and refocusing its strategic approach to the American market.
See More
Aegon Appoints New President and Moves Headquarters to New York
- Executive Appointment: Aegon announced the appointment of Will Fuller, President and CEO of Transamerica, as President and COO effective January 1, 2027, which is expected to enhance daily management efficiency and strengthen international business integration.
- Headquarters Relocation: Aegon has selected New York City as its future corporate headquarters, set to open in mid-2027, aiming to support strategic execution by centralizing leadership and key functions in the U.S. market.
- Strategic Objectives: The leadership changes and headquarters move are intended to facilitate Aegon's ambition to become a U.S.-based life insurance and retirement business, reflecting its commitment to the American market and long-term growth plans.
- Market Reaction: Following the announcement of the executive changes, Aegon's stock price rose 1.53% to $8.65 on the New York Stock Exchange, indicating positive market expectations regarding the company's future strategy.
See More
Aegon Reaches Governance Agreement with Major Shareholder
- Governance Framework Update: Aegon has reached a comprehensive agreement with its largest shareholder, Vereniging Aegon, aimed at supporting the company's relocation to the U.S. by aligning its governance structure with U.S. capital market standards, thereby enhancing its competitiveness in the U.S. life insurance and retirement sectors.
- Board Structure Reform: The agreement proposes a phased removal of the staggered board structure, with annual director elections starting in 2030 and the implementation of majority voting in uncontested elections, which will improve governance transparency and shareholder engagement.
- Capital Structure Simplification: Aegon plans to convert all outstanding common shares B held by Vereniging Aegon on a 1:40 basis into a single class of common stock, ensuring equal voting rights for all shareholders while authorizing a new class of preferred stock to optimize capital allocation.
- Charitable Donation and Restructuring: Vereniging Aegon will be renamed Vereniging Aegon Americas and will donate €500 million to the newly established Stichting Aegon Fonds Nederland to support its community and charitable initiatives in the Netherlands, reflecting the company's commitment to social responsibility.
See More
Aegon to Sell Aegon UK to Standard Life for £2 Billion
- Transaction Value: Aegon is selling Aegon UK to Standard Life for a total consideration of £2 billion, which includes a 15.3% stake in Standard Life plc (approximately 181.1 million shares) and £0.75 billion in cash, significantly enhancing Standard Life's market position.
- Cash Utilization: Following the transaction, Aegon plans to use the cash received, after deducting expected remittances from Aegon UK, for deleveraging and share buybacks, which will help improve the company's financial structure and enhance shareholder returns.
- Financial Guidance Update: After the completion of the transaction, Aegon will update its group financial guidance for 2026 and 2027, with an expected annual growth rate of around 5% in group operating results from 2025 to 2027, indicating the company's growth potential in the future.
- Asset Management Retention: Despite the sale of Aegon UK, Aegon's asset management activities in the UK will remain part of its global asset manager, serving as an important partner for the new combined business, ensuring its competitiveness in the market.
See More
Aegon Sells UK Business to Standard Life for £2 Billion
- Transaction Value: Aegon has entered into an agreement to sell its UK business to Standard Life for £2 billion, part of its strategy to focus on the U.S. life insurance and retirement sector, with the deal expected to close by the end of 2026.
- Equity Structure: The transaction includes a 15.3% stake in Standard Life, equivalent to 181.1 million shares, alongside a cash component of £0.75 billion, which will be reduced by any remittances from Aegon UK between signing and closing.
- Financial Impact: The deal values Aegon UK at 14.2 times its 2025 operating result after tax and 1.9 times its 2025 IFRS shareholders' equity, with proceeds expected to be used for deleveraging and share buybacks post-completion.
- Board Appointment: Following the completion of the transaction, Aegon will have the right to appoint one non-executive director to Standard Life's board, thereby enhancing its influence in the new investment.
See More
Aegon Board Proposes CEO Tenure Extension to 2030
- CEO Tenure Proposal: Aegon's board plans to propose Lard Friese's extension as CEO until 2030 at the annual meeting on June 10, 2026, ensuring leadership continuity during the company's relocation to the US and enhancing strategic execution.
- Confidence in Leadership: Chairman David Herzog stated that Friese's performance since May 2020 has proven his capabilities, and the board is confident in his collaboration with the Executive Committee to continue creating sustainable long-term value for all stakeholders.
- Strategic Objectives: The tenure extension proposal aims to support Aegon's ambition to become a leading life insurance and retirement group in the US, emphasizing the company's growth potential and aspirations in the global market, particularly in the US.
- Shareholder Returns: Aegon also proposed a final dividend of €0.21 per common share for 2025, demonstrating the company's commitment to shareholder returns while continuing to focus on growth.
See More
Aegon Restructures Leadership to Accelerate Strategic Execution
- Leadership Restructuring: Aegon has announced a leadership restructuring effective January 1, 2027, with Will Fuller assuming the role of President and COO, aimed at accelerating strategic execution and supporting the planned relocation of its global headquarters to the U.S.
- Headquarters Relocation: Aegon has officially selected New York City as the location for its future global headquarters, with a new office set to open in mid-2027, which will consolidate core corporate functions and enhance collaboration among the executive leadership team.
- Executive Experience: Will Fuller, who has served as President and CEO of Transamerica since March 2021, brings extensive industry experience from senior roles at Lincoln Financial Group and Merrill Lynch, and will oversee the day-to-day management of Transamerica and Aegon’s international businesses.
- Governance Reform Partnership: Aegon is partnering with major shareholders to overhaul its governance structure to support its relocation plans in the U.S., further simplifying and refocusing its strategic approach to the American market.
See More
Aegon Appoints New President and Moves Headquarters to New York
- Executive Appointment: Aegon announced the appointment of Will Fuller, President and CEO of Transamerica, as President and COO effective January 1, 2027, which is expected to enhance daily management efficiency and strengthen international business integration.
- Headquarters Relocation: Aegon has selected New York City as its future corporate headquarters, set to open in mid-2027, aiming to support strategic execution by centralizing leadership and key functions in the U.S. market.
- Strategic Objectives: The leadership changes and headquarters move are intended to facilitate Aegon's ambition to become a U.S.-based life insurance and retirement business, reflecting its commitment to the American market and long-term growth plans.
- Market Reaction: Following the announcement of the executive changes, Aegon's stock price rose 1.53% to $8.65 on the New York Stock Exchange, indicating positive market expectations regarding the company's future strategy.
See More
Aegon Reaches Governance Agreement with Major Shareholder
- Governance Framework Update: Aegon has reached a comprehensive agreement with its largest shareholder, Vereniging Aegon, aimed at supporting the company's relocation to the U.S. by aligning its governance structure with U.S. capital market standards, thereby enhancing its competitiveness in the U.S. life insurance and retirement sectors.
- Board Structure Reform: The agreement proposes a phased removal of the staggered board structure, with annual director elections starting in 2030 and the implementation of majority voting in uncontested elections, which will improve governance transparency and shareholder engagement.
- Capital Structure Simplification: Aegon plans to convert all outstanding common shares B held by Vereniging Aegon on a 1:40 basis into a single class of common stock, ensuring equal voting rights for all shareholders while authorizing a new class of preferred stock to optimize capital allocation.
- Charitable Donation and Restructuring: Vereniging Aegon will be renamed Vereniging Aegon Americas and will donate €500 million to the newly established Stichting Aegon Fonds Nederland to support its community and charitable initiatives in the Netherlands, reflecting the company's commitment to social responsibility.
See More
Aegon to Sell Aegon UK to Standard Life for £2 Billion
- Transaction Value: Aegon is selling Aegon UK to Standard Life for a total consideration of £2 billion, which includes a 15.3% stake in Standard Life plc (approximately 181.1 million shares) and £0.75 billion in cash, significantly enhancing Standard Life's market position.
- Cash Utilization: Following the transaction, Aegon plans to use the cash received, after deducting expected remittances from Aegon UK, for deleveraging and share buybacks, which will help improve the company's financial structure and enhance shareholder returns.
- Financial Guidance Update: After the completion of the transaction, Aegon will update its group financial guidance for 2026 and 2027, with an expected annual growth rate of around 5% in group operating results from 2025 to 2027, indicating the company's growth potential in the future.
- Asset Management Retention: Despite the sale of Aegon UK, Aegon's asset management activities in the UK will remain part of its global asset manager, serving as an important partner for the new combined business, ensuring its competitiveness in the market.
See More
Aegon Sells UK Business to Standard Life for £2 Billion
- Transaction Value: Aegon has entered into an agreement to sell its UK business to Standard Life for £2 billion, part of its strategy to focus on the U.S. life insurance and retirement sector, with the deal expected to close by the end of 2026.
- Equity Structure: The transaction includes a 15.3% stake in Standard Life, equivalent to 181.1 million shares, alongside a cash component of £0.75 billion, which will be reduced by any remittances from Aegon UK between signing and closing.
- Financial Impact: The deal values Aegon UK at 14.2 times its 2025 operating result after tax and 1.9 times its 2025 IFRS shareholders' equity, with proceeds expected to be used for deleveraging and share buybacks post-completion.
- Board Appointment: Following the completion of the transaction, Aegon will have the right to appoint one non-executive director to Standard Life's board, thereby enhancing its influence in the new investment.
See More
Aegon Board Proposes CEO Tenure Extension to 2030
- CEO Tenure Proposal: Aegon's board plans to propose Lard Friese's extension as CEO until 2030 at the annual meeting on June 10, 2026, ensuring leadership continuity during the company's relocation to the US and enhancing strategic execution.
- Confidence in Leadership: Chairman David Herzog stated that Friese's performance since May 2020 has proven his capabilities, and the board is confident in his collaboration with the Executive Committee to continue creating sustainable long-term value for all stakeholders.
- Strategic Objectives: The tenure extension proposal aims to support Aegon's ambition to become a leading life insurance and retirement group in the US, emphasizing the company's growth potential and aspirations in the global market, particularly in the US.
- Shareholder Returns: Aegon also proposed a final dividend of €0.21 per common share for 2025, demonstrating the company's commitment to shareholder returns while continuing to focus on growth.
See More
